Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.
Am J Hematol
; 97(2): E51-E54, 2022 02 01.
Article
in En
| MEDLINE
| ID: mdl-34778998
Full text:
1
Database:
MEDLINE
Main subject:
Complement Inactivating Agents
/
Antibodies, Monoclonal, Humanized
/
Anemia, Hemolytic, Autoimmune
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Am J Hematol
Year:
2022
Type:
Article
Affiliation country:
Norway